Journal of the American Society of Hypertension
Volume 3, Issue 1 , Pages 19-24.e2 , January 2009

Prevalence, awareness, and control of arterial hypertension in Denmark

  • Christel N. Kronborg, MD, PhD
    • ,
  • Jesper Hallas, MD, DMSc
    • ,
  • Ib A. Jacobsen, MD, DMSc

      Affiliations

    • Corresponding Author InformationCorresponding author: Ib A. Jacobsen, MD, DMSc, Department of Endocrinology M, Odense University Hospital, DK-5000 Odense, Denmark. Tel: +45 2720313; fax: +45 65919653

Received 12 May 2008 ,Accepted 1 August 2008.

References 

  1. Ezzati M, Lopez AD, Rodgers A, van der Horn S, Murray CJL. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347–1360
  2. WHO. World health report 2002; reducing risk, promoting healthy life. Geneva, Switzerland: World Health Organization; 2002;
  3. Blood Pressure Lowering Treatment Trialists' Collaboration. Effect of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trails. Lancet. 2003;362:1527–1535
  4. Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens. 2002;20:1461–1464
  5. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton P, He Jiang . Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22:11–19
  6. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton P, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–223
  7. Burt VL, Cutler AJ, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment and control of hypertension in the US adult population. Hypertension. 1995;26:60–69
  8. Sehested T, Ibsen H, Jøgensen T. Awareness, treatment and control of hypertension in Denmark (The Inter99 study). Blood Press. 2007;16:312–319
  9. Rogoza AN, Pavlova TS, Sergeeva MV. Validation of A&D UA-676 device for self-measurement of blood pressure. Blood Press Monitor. 2000;5:227–231
  10. 2003 European Society of Hypertension-European Society of Cardiology guide lines for the management of arterial hypertension. J Hypertens. 2003;21:1011–1053
  11. Klungel OH, de Boer A, Paes AHP, Nagelkerke NJD, Seidell JC, Bakker A. Estimating the prevalence of hypertension corrected for the effect of within-person variability in blood pressure. J Clin Epidemiol. 2000;53:1158–1163
  12. Longo D, Dorigatti P, Palatini F. Masked hypertension in adults. Blood Press Monitor. 2005;10:307–310
  13. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension. 2002;40:795–796
  14. Mancia G. Effective ambulatory blood pressure control in medical practice. Hypertension. 2007;49:17–18
  15. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation. 1993;88:1973–1998
  16. Erdine S. Eur Soc Hypertens Scient Newsl 2007. www.eshonline.org/education/newsletter/2007_03.pdf
  17. Orduñez-Garcia P, Bernal Munoz JL, Pedraza D, Espinosa-Brito A, Silva LC, Cooper RS. Success in control of hypertension in a low-resource setting: the Cuban experience. J Hypertens. 2006;24:845–849
  18. Banegas JR, Segura J, Sobrino J, Rodríguez-Artalejo F, de la Sierra A, de la Cruz JJ, et al. Effectiveness of blood pressure control outside the medical setting. Hypertension. 2007;49:62–68
  19. Ong KL, Cheung BMY, Man YB, Lau CP, Lam KSL. Prevalence, awareness, treatment, and control of hypertension among Unites States adults 1999–2004. Hypertension. 2007;49:69–75
  20. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel inhibitor vs. diuretic (The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)). JAMA. 2002;288:2981–2997
  21. Levey SA, Coresh J, Greene T, Stevens LA, Zhang Y, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study (Equation for estimating glomerular filtration rate). Ann Intern Med. 2006;145:247–254
  22. Onysko J, Maxwell C, Eliaziw M, Zhang JX, Johansen H, Campbell NRC. Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program. Hypertension. 2006;48:853–860
  23. Drouin D, Kaczorowski J, Campbell NR, Lewanczuk RR. Implementing guidelines (It is working in Canada). Berlin, Germany: ESH/ISH Scientific Meeting; 2008;Abstract OS 14/1

 This study was funded by Apotekerfonden of 1991, The Danish Heart Foundation, The University of Southern Denmark, the County of Funen, and to a smaller extent by Pfizer, Novartis, Boehringer-Ingelheim, Solvay, and Sanofi-Synthelabo. Dr. Hallas has received research Grants from Novartis, Nycomed, and Merck Sharp & Dohme, and fees for teaching from Astra-Zeneca, Nycomed, Pfizer, and the Danish Association of Pharmaceutical Industry.

 Supplemental Material is available at www.ashjournal.com.

PII: S1933-1711(08)00148-4

doi: 10.1016/j.jash.2008.08.001

Journal of the American Society of Hypertension
Volume 3, Issue 1 , Pages 19-24.e2 , January 2009

Article Tools

* Image Usage & Resolution